Apeloa Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -12.92% vs -14.55% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 38.95% vs -56.41% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,019.70",
          "val2": "2,319.40",
          "chgp": "-12.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "310.30",
          "val2": "329.70",
          "chgp": "-5.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7.20",
          "val2": "6.20",
          "chgp": "16.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "190.50",
          "val2": "137.10",
          "chgp": "38.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "67.20%",
          "val2": "66.90%",
          "chgp": "0.03%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -18.65% vs 5.07% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -13.59% vs -2.32% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9,758.80",
          "val2": "11,996.50",
          "chgp": "-18.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,557.00",
          "val2": "1,606.40",
          "chgp": "-3.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "27.80",
          "val2": "35.50",
          "chgp": "-21.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.30",
          "val2": "8.10",
          "chgp": "-96.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "890.70",
          "val2": "1,030.80",
          "chgp": "-13.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "90.10%",
          "val2": "85.20%",
          "chgp": "0.49%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

2,019.70

2,319.40

-12.92%

Operating Profit (PBDIT) excl Other Income

310.30

329.70

-5.88%

Interest

7.20

6.20

16.13%

Exceptional Items

-0.00

0.10

-100.00%

Consolidate Net Profit

190.50

137.10

38.95%

Operating Profit Margin (Excl OI)

67.20%

66.90%

0.03%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is -12.92% vs -14.55% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 38.95% vs -56.41% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

9,758.80

11,996.50

-18.65%

Operating Profit (PBDIT) excl Other Income

1,557.00

1,606.40

-3.08%

Interest

27.80

35.50

-21.69%

Exceptional Items

0.30

8.10

-96.30%

Consolidate Net Profit

890.70

1,030.80

-13.59%

Operating Profit Margin (Excl OI)

90.10%

85.20%

0.49%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -18.65% vs 5.07% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -13.59% vs -2.32% in Dec 2024

All Annual Results